We are live on ! Find out more
PFC

Phocas Financial Corp Portfolio holdings

AUM $721M
1-Year Est. Return 63.77%
This Fund
S&P 500
This Quarter Est. Return
+29.34%
1 Year Est. Return
+63.77%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$721M
AUM Growth
+$83.9M
Cap. Flow
-$47.5M
Cap. Flow %
-6.59%
Top 10 Hldgs %
17.87%
Holding
170
New
15
Increased
11
Reduced
103
Closed
17

Sector Composition

Rank Sector Weight
1 Financials 25.27%
2 Industrials 15.23%
3 Healthcare 11.47%
4 Technology 11.37%
5 Real Estate 8.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LZB icon
101
La-Z-Boy
LZB
$1.3B
$3.22M 0.45%
80,161
-4,267
-5% -$154K
GOOGL icon
102
Alphabet (Google) Class A
GOOGL
$4.24T
$3.05M 0.42%
8,524
MHO icon
103
M/I Homes
MHO
$3.83B
$3.03M 0.42%
18,865
-1,028
-5% -$138K
FUL icon
104
H.B. Fuller
FUL
$3.03B
$2.81M 0.39%
48,140
-2,543
-5% -$156K
SUPN icon
105
Supernus Pharmaceuticals
SUPN
$2.54B
$2.8M 0.39%
60,253
-3,160
-5% -$152K
SCHX icon
106
Schwab US Large- Cap ETF
SCHX
$74.3B
$2.74M 0.38%
93,009
-2,985
-3% -$85.2K
SR icon
107
Spire
SR
$4.88B
$2.66M 0.37%
34,000
-1,767
-5% -$152K
CUZ icon
108
Cousins Properties
CUZ
$4.85B
$2.58M 0.36%
86,145
-4,576
-5% -$120K
AAPL icon
109
Apple
AAPL
$4.67T
$2.52M 0.35%
8,706
-148
-2% -$42.3K
NVDA icon
110
NVIDIA
NVDA
$5.25T
$2.49M 0.35%
12,430
-945
-7% -$194K
NRIX icon
111
Nurix Therapeutics
NRIX
$2.72B
$2.42M 0.34%
+99,589
New +$1.7M
JJSF icon
112
J&J Snack Foods
JJSF
$1.67B
$2.2M 0.3%
29,908
-1,555
-5% -$121K
VCYT icon
113
Veracyte
VCYT
$3.48B
$2.19M 0.3%
37,297
-1,973
-5% -$82.7K
CYTK icon
114
Cytokinetics
CYTK
$10B
$2.1M 0.29%
+24,634
New +$1.77M
PTGX icon
115
Protagonist Therapeutics
PTGX
$9.34B
$2.01M 0.28%
+16,378
New +$1.71M
ACAD icon
116
Acadia Pharmaceuticals
ACAD
$5.02B
$1.95M 0.27%
77,245
-4,102
-5% -$90.3K
DNLI icon
117
Denali Therapeutics
DNLI
$3.84B
$1.83M 0.25%
+71,197
New +$1.46M
IDYA icon
118
IDEAYA Biosciences
IDYA
$3.87B
$1.82M 0.25%
+48,822
New +$1.49M
ETN icon
119
Eaton
ETN
$156B
$1.74M 0.24%
4,090
MIRM icon
120
Mirum Pharmaceuticals
MIRM
$5.94B
$1.71M 0.24%
+14,637
New +$1.47M
MSFT icon
121
Microsoft
MSFT
$3.81T
$1.52M 0.21%
4,080
JNJ icon
122
Johnson & Johnson
JNJ
$646B
$1.38M 0.19%
5,449
-66
-1% -$15.4K
ARQT icon
123
Arcutis Biotherapeutics
ARQT
$2.99B
$1.25M 0.17%
47,746
-2,553
-5% -$59.5K
BRK.B icon
124
Berkshire Hathaway Class B
BRK.B
$1.08T
$1.12M 0.16%
2,237
CSD icon
125
Invesco S&P Spin-Off ETF
CSD
$224M
$1.11M 0.15%
7,400

Similar funds

Phocas Financial Corp's Q2 2026 Portfolio in Review

As of Q2 2026, Phocas Financial Corp held 170 positions worth $721M, up 13% from $637M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Phocas Financial Corp withdrew a net $47.5M in Q2 2026, closing 17 positions and reducing 103 holdings. Its most notable exit was Tri Pointe Homes, an estimated $7.71M position sold in full.

By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 25% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Phocas Financial Corp opened a new position in Murphy Oil worth $3.3M.

  • Phocas Financial Corp's largest Q2 2026 buy was Murphy Oil: 101,370 shares worth $3.3M.
  • Phocas Financial Corp added most to MDU Resources in Q2 2026, an estimated $3.44M increase.
  • Phocas Financial Corp's biggest Q2 2026 reduction was Sanmina, cutting an estimated $6.62M.
  • Phocas Financial Corp fully exited Tri Pointe Homes in Q2 2026, selling an estimated $7.71M.
  • Phocas Financial Corp's ten largest holdings make up 18% of its $721M portfolio in Q2 2026.
  • Phocas Financial Corp opened 15 new positions and closed 17 in Q2 2026.
  • Phocas Financial Corp's portfolio value rose 13% quarter-over-quarter to $721M.

Based on Phocas Financial Corp's 13F filing for Q2 2026, filed 31 Jul 2026.